Anfarm Hellas

Anfarm Hellas S.A. is a leading EU GMP-certified pharmaceutical company dedicated to producing high-quality generic medicines for global markets. Established in 1967 by Apostolos Nicolaou, the company has grown into a trusted partner for healthcare providers and multinational pharmaceutical companies worldwide.

Filter

About Anfarm Hellas S.A.

With a commitment to innovation, quality, and tradition, Anfarm Hellas combines decades of expertise with cutting-edge manufacturing technologies. Its state-of-the-art facilities, located in Schimatari, Viotia, Greece, are equipped to meet the rigorous standards of both EU GMP and numerous national health authorities.

Anfarm Hellas specializes in developing and manufacturing generic pharmaceuticals that meet the needs of patients and healthcare providers across diverse therapeutic areas.

Product Portfolio

Anfarm Hellas offers a comprehensive range of pharmaceutical products, focusing on:

1. Generic Pharmaceuticals

  • β-lactams.
  • Liquid injectables.
  • Lyophilized products optimized for quality and efficacy.

2. Lyophilization Services

  • Anfarm operates a dedicated lyophilization facility with a capacity to produce over 40 million vials annually.
  • The company excels in optimizing commercial products and supporting those under development, ensuring high-quality outcomes.

Manufacturing Excellence

Anfarm Hellas’ manufacturing facilities are designed to meet the highest international standards.

Key Features:

  • EU GMP Certification: Guarantees compliance with stringent quality standards.
  • Advanced Technology: Incorporates state-of-the-art equipment to ensure precision and efficiency.
  • Global Accreditation: Approved by health authorities in Europe, Canada, South Africa, and beyond.

Global Presence and Export Markets

Anfarm Hellas has established a strong global footprint, with its products and services reaching diverse markets:

  • Europe and Canada: Trusted for quality and reliability.
  • Emerging Markets: Active in MENA (Middle East and North Africa), LATAM (Latin America), and APAC (Asia-Pacific) regions.

The company’s focus on licensing, exports, and third-party manufacturing has solidified its reputation as a dependable pharmaceutical partner.

Research and Development

Innovation drives Anfarm Hellas’ success. The company invests heavily in R&D to develop high-value generic products that align with global healthcare demands.

R&D Activities Include:

  • Formulation development.
  • Analytical development.
  • Optimization of generic medicines to enhance efficacy and patient outcomes.

Business Development and Partnerships

Anfarm Hellas is a trusted partner for multinational pharmaceutical companies, offering:

  • Expertise in production and regulatory compliance.
  • Proven reliability in delivering quality products.
  • Flexibility to adapt to evolving market needs.

By leveraging its long-standing experience, Anfarm Hellas continues to build strong partnerships across the pharmaceutical industry.

Recent Achievements

  • Recognized as a Leading Greek Company: In 2023, Anfarm Hellas was named among the 15 most dynamic companies in Greece, reflecting its ongoing growth and innovation.
  • Expanded Global Reach: Strengthened its presence in key markets, further establishing itself as a global leader in generic pharmaceuticals.

Why Choose Anfarm Hellas S.A.?

  1. Trusted Quality: EU GMP-certified and globally accredited products.
  2. Diverse Offerings: Specializes in generic pharmaceuticals, lyophilization, and injectable products.
  3. Global Reach: Strong presence in established and emerging markets.
  4. Innovation-Driven: Continuous investment in R&D to meet global healthcare needs.
  5. Reliable Partnerships: A proven track record with multinational companies.

Conclusion

With over five decades of experience, Anfarm Hellas S.A. is a trusted name in the pharmaceutical industry. Its dedication to quality, innovation, and global collaboration ensures it remains a leader in generic medicine manufacturing.